药品名称TAGAMET
申请号017920产品号004
活性成分CIMETIDINE市场状态停止上市
剂型或给药途径TABLET;ORAL规格400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1983/12/14申请机构GLAXOSMITHKLINE
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
017920095APLetter2006/07/21下载
017920094APLetter2005/12/16下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
017920095AP2006/07/12Labeling Revision
017920094AP2005/12/14Labeling Revision
017920092AP1998/07/29Control Supplement
017920091AP1998/07/14Package Change
017920090AP1997/04/15Control Supplement
017920089AP1996/07/16Manufacturing Change or Addition
017920088AP1996/01/19Control Supplement
017920087AP1995/02/22Labeling Revision
017920086AP1993/11/10Manufacturing Change or Addition
017920085AP1993/09/29Control Supplement
017920084AP1993/06/08Manufacturing Change or Addition
017920082AP1992/07/16Control Supplement
017920081AP1992/01/07Labeling Revision
017920080AP1992/08/27Control Supplement
017920078AP1991/11/13Labeling Revision
017920077AP1989/11/13Labeling Revision
017920075AP1990/05/30Control Supplement
017920074AP1991/03/07New or Modified Indication
017920073AP1989/06/26Labeling Revision
017920072AP1989/06/26Labeling Revision
017920069AP1988/06/15Labeling Revision
017920068AP1988/05/20Labeling Revision
017920067AP1988/03/31New Dosage Regimen
017920066AP1986/04/29New or Modified Indication
017920065AP1986/04/23Labeling Revision
017920064AP1986/01/13Labeling Revision
017920063AP1985/12/18Manufacturing Change or Addition
017920062AP1986/04/30Control Supplement
017920061AP1985/04/18Labeling Revision
017920059AP1985/02/07Labeling Revision
017920057AP1986/04/29New Dosage Regimen
017920055AP1984/09/26Package Change
017920054AP1984/06/18Labeling Revision
017920053AP1984/07/19Labeling Revision
017920052AP1984/03/22Labeling Revision
017920051AP1984/03/05Labeling Revision
017920050AP1983/09/23Manufacturing Change or Addition
017920048AP1984/07/19Labeling Revision
017920047AP1983/12/14General Efficacy (MarkIV)
017920045AP1983/02/28Labeling Revision
017920044AP1983/01/31General Efficacy (MarkIV)
017920043AP1984/12/27General Efficacy (MarkIV)
017920042AP1983/01/04Control Supplement
017920041AP1982/08/25General Efficacy (MarkIV)
017920038AP1982/01/22Labeling Revision
017920037AP1981/11/02Labeling Revision
017920036AP1981/07/13Labeling Revision
017920035AP1982/12/30Labeling Revision
017920032AP1981/01/22Labeling Revision
017920031AP1981/01/22Labeling Revision
017920030AP1982/12/30General Efficacy (MarkIV)
017920029AP1981/06/02Formulation Revision
017920028AP1980/07/08Labeling Revision
017920027AP1980/07/08Labeling Revision
017920026AP1980/07/08Labeling Revision
017920024AP1980/04/23Labeling Revision
017920023AP1981/08/28Expiration Date Change
017920022AP1980/01/07Package Change
017920019AP1979/06/29Labeling Revision
017920018AP1980/01/08Control Supplement
017920017AP1980/04/23General Efficacy (MarkIV)
017920016AP1979/02/01Labeling Revision
017920015AP1979/02/28Control Supplement
017920014AP1978/11/30Labeling Revision
017920013AP1978/11/30Labeling Revision
017920011AP1978/09/28Labeling Revision
017920009AP1978/09/28Manufacturing Change or Addition
017920008AP1980/04/23General Efficacy (MarkIV)
017920005AP1978/03/16Expiration Date Change
017920004AP1977/11/30Labeling Revision
017920003AP1977/11/30Labeling Revision
017920001AP1978/03/17Labeling Revision
017920000AP1977/08/16Approval